Skip to main content
    M

    MDxHealth SA (MDXH)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $0.15
    +0.00 (+3.40%)

    Market Cap: $13.75M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    MDxHealth SA (MDXH) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to MDxHealth SA are Precipio (PRPO), bioAffinity Technologies (BIAF) and XWELL (XWEL). By market cap, MDxHealth SA ranks 11th of the 13 companies on this page; GRAIL, LLC (GRAL) is the largest at $5.21B.

    Peer Comparison

    MDXH's ROIC of -40.5% is below the peer median of -17.6%, and its revenue growth of -17.2% is below the median of -0.8%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    MDxHealth SA (MDXH)$13.75MN/AN/A-38.3%-40.5%-17.2%0.00%
    Precipio Inc (PRPO)$39.68MN/A1.3x-4.1%-5.7%8.3%0.00%
    bioAffinity Technologies, Inc. (BIAF)$4.00MN/A0.3x-278.9%-376.1%-26.0%0.00%
    XWELL Inc. (XWEL)$5.62MN/A0.2x-82.9%N/A-7.1%0.00%
    CareDx Inc (CDNA)$4.09B48.2x6.4x25.9%N/A39.3%0.00%
    Castle Biosciences Inc (CSTL)$1.04BN/A2.7x-6.1%-5.4%23.9%0.00%
    GRAIL, LLC (GRAL)$5.21BN/A29.6x-243.8%N/A3.7%0.00%
    Myriad Genetics Inc (MYGN)$542.92MN/A0.7x-16.1%-29.5%-1.5%0.00%
    Marker Therapeutics Inc (MRKR)$14.51MN/A14.5x-245.5%N/A-51.0%0.00%
    Insight Molecular Diagnostics Inc. (IMDX)$70.03MN/A40.9x0.0%197.8%-53.9%0.00%
    TherapeuticsMD Inc (TXMD)$21.64MN/A5.6x-6.6%N/A-8.7%0.00%
    Exagen Inc (XGN)$105.37MN/A1.3x-25.1%-40.4%6.8%0.00%
    Context Therapeutics Inc (CNTX)$16.61MN/AN/A0.0%N/A0.0%0.00%
    Peer median$54.85M48.2x2.7x-11.4%-17.6%-0.8%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to MDxHealth SA, ranked by how closely their business, size, sector and industry match. The largest group, 9 of the 12, is in Diagnostics & Research; the other 3 span 2 industries.

    CompanyAboutPeers
    Precipio Inc (PRPO)Diagnostics & Research
    Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market.
    PRPO competitors
    bioAffinity Technologies, Inc. (BIAF)Diagnostics & Research
    bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer.
    BIAF competitors
    XWELL Inc. (XWEL)Diagnostics & Research
    XWELL Inc., a health and wellness services company, provides spa services at airports. The company is headquartered in New York, New York.
    XWEL competitors
    CareDx Inc (CDNA)Diagnostics & Research
    CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally.
    CDNA competitors
    Castle Biosciences Inc (CSTL)Diagnostics & Research
    Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests...
    CSTL competitors
    GRAIL, LLC (GRAL)Diagnostics & Research
    GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics...
    GRAL competitors
    Myriad Genetics Inc (MYGN)Diagnostics & Research
    Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized...
    MYGN competitors
    Marker Therapeutics Inc (MRKR)Biotechnology
    Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based...
    MRKR competitors
    Insight Molecular Diagnostics Inc. (IMDX)Diagnostics & Research
    OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
    IMDX competitors
    TherapeuticsMD Inc (TXMD)Drug Manufacturers - Specialty & Generic
    TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida.
    TXMD competitors
    Exagen Inc (XGN)Diagnostics & Research
    Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name...
    XGN competitors
    Context Therapeutics Inc (CNTX)Biotechnology
    Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid...
    CNTX competitors

    Frequently Asked Questions About MDXH

    Who are MDxHealth SA's main competitors?

    The companies most similar to MDxHealth SA include Precipio (PRPO), bioAffinity Technologies (BIAF), XWELL (XWEL), CareDx (CDNA) and Castle Biosciences (CSTL), listed from the closest match.

    Who is MDxHealth SA's biggest competitor?

    GRAIL, LLC (GRAL) is the largest of the similar companies at $5.21B; Precipio (PRPO) is the closest match by business profile, size, sector and industry.

    How does MDXH stock compare with its competitors?

    MDXH's net margin is -38.3% against a peer median of -11.4%.

    Which of MDxHealth SA's competitors pays a higher dividend?

    MDxHealth SA pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is MDxHealth SA bigger than its competitors?

    No. MDxHealth SA is 11th by market cap among the 13 companies on this page; the largest is GRAIL, LLC (GRAL) at $5.21B.